现货大促销,价格低至8折起,量大更优惠,详细咨询客服
全部分类
全部分类
  • NVP-BSK805 dihydrochloride
NVP-BSK805 dihydrochloride的可视化放大

NVP-BSK805 dihydrochloride

A potent, selective JAK2 inhibitor

价格
0-8200
NVP-BSK805 dihydrochloride的二维码

所有产品仅用于科学研究,我们不为任何个人用途提供产品和服务

询价有惊喜,量大更优惠 点击这里给我发消息

  • 库存: 现货
可选包装 >>>
首页
  • 货号: ajce57808
  • CAS: 1942919-79-0
  • 别名:
  • 分子式: C27H30Cl2F2N6O
  • 分子量: 563.47
  • 纯度: >98%
  • 溶解度: DMSO: 50 mg/mL (88.74 mM)
  • 储存: Store at -20°C
  • 库存: 现货

Background

Janus kinases (JAKs) are non-receptor tyrosine kinases that mediate signaling through cytokine receptors, often to members of the signal transducer and activator of transcription (STAT) family.1 A point mutation of JAK2, V617F, activates signaling through STAT5 and drives certain forms of cancer.2 NVP-BSK805 is a potent inhibitor of JAK2 that also inhibits the JAK2V617F mutant enzyme (IC50s for both enzymes ~ 0.5 nM). It displays at least 20-fold selectivity against other JAK enzymes and a panel of serine/threonine and tyrosine kinases.2 This ATP-competitive inhibitor is orally bioavailable and has a long half-life in vivo, suppressing leukemic cell spreading and splenomegaly in JAK2V617F cell-driven disease in mice.2 NVP-BSK805 suppresses recombinant human erythropoietin-induced polycythemia and extramedullary erythropoiesis in mice and rats.2 NVP-BSK805 can be used to study the molecular mechanisms involved in JAK2V617F signaling in cells.3


1.Yamaoka, K., Saharinen, P., Pesu, M., et al.The Janus kinases (Jaks)Genome Biol.5(12)253(2004) 2.Baffert, F., Régnier, C.H., De Pover, A., et al.Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805Mol. Cancer Ther.9(7)1945-1955(2010) 3.Rubert, J., Qian, Z., Andraos, R., et al.Bim and Mcl-1 exert key roles in regulating JAK2V617F cell survivalBMC Cancer11:24(2011)

动态评分

0.0

没有评分数据
没有评价数据
一键回到顶部
展开 收缩
安捷凯在线客服